Mupiderm (Mupirocin)

Mupirocin, the active ingredient in Mupiderm, is a topical antibacterial presented as a cream for skin application. It is used to treat superficial bacterial skin infections such as impetigo and secondary infections of dermatitis, targeting Gram‑positive organisms including Staphylococcus aureus and Streptococcus pyogenes. The medication is supplied in a dosage form suitable for direct application to the affected area, following a prescriber's instructions.

GNH USA supplies Mupiderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibacterial that acts on superficial skin infections caused by susceptible bacteria.

- Impetigo: reduces bacterial load and promotes healing of the characteristic crusted lesions. - Secondary bacterial infections of dermatitis: eliminates colonising pathogens and aids resolution of inflamed skin. - Other superficial skin infections: treats localized infections such as folliculitis and minor abrasions infected with Gram‑positive bacteria.

Mupirocin is generally well tolerated when applied to intact skin, but local reactions may occur.

Common Side Effects: - Local skin irritation: mild redness or itching at the application site. - Burning sensation: transient warmth or tingling after application. - Dryness: mild scaling or flaking of the treated area. - Erythema: mild redness without swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering requiring medical attention. - Contact urticaria: hives localized to the area of application. - Systemic hypersensitivity: rare anaphylactic reactions presenting with generalized symptoms.

Before using Mupiderm, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: avoid application on broken skin and discuss risks with a clinician. - Pediatric use: safety in infants under two months has not been established. - Concurrent antibiotic therapy: monitor for potential resistance development. - Extensive application: avoid covering large body surface areas or mucous membranes. - Store at room temperature: keep in the original container, protect from moisture and light.

Mupirocin may interact with other topical agents; consider the following.

Major Interactions (Avoid): - Systemic antibiotics with overlapping spectrum: may increase risk of bacterial resistance. - Topical corticosteroids: can reduce the antibacterial efficacy of mupirocin. - Other topical antimicrobials: concurrent use may heighten skin irritation.

Moderate Interactions (Monitor Closely): - Antifungal creams: watch for additive irritation at the site. - Iodine‑containing dressings: may affect drug absorption. - Chemotherapeutic agents: monitor wound healing when used together.